TARSIME 750 mg Powder

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Tarsime

Contents of the leaflet

  1. Package Leaflet: Information for the Patient
  2. TARSIME, 750 mg, powder for solution for injection or infusion
  3. TARSIME, 1500 mg, powder for solution for injection and infusion
    1. Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.
    2. Contents of the Package Leaflet
  4. What is Tarsime and what is it used for
    1. Tarsime is used to treat infections of:
  5. Important information before taking Tarsime
    1. When not to take Tarsime:
    2. Warnings and precautions
    3. Blood and urine tests
    4. Tarsime and other medicines
    5. Oral contraceptives
    6. Pregnancy, breastfeeding, and fertility
    7. Driving and using machines
    8. Tarsime, 750 mg contains 38.6 mg of sodium (the main component of common salt) per vial.
    9. Tarsime, 1500 mg contains 77.3 mg of sodium (the main component of common salt) per vial.
  6. How to take Tarsime
    1. Newborns and infants (0-3 weeks old)
    2. Infants (over 3 weeks old) and children weighing less than 40 kg
    3. Adults and children weighing over 40 kg
    4. Patients with kidney problems
  7. Possible side effects
    1. Symptoms to watch for
    2. If you experience any of these symptoms, contact your doctor or nurse immediately.
    3. Other side effects that may occur during treatment
    4. Frequent side effects (in 1 to 10 per 100 patients):
    5. Uncommon side effects (in 1 to 10 per 1,000 patients):
    6. Side effects with unknown frequency:
    7. Reporting side effects
  8. How to store Tarsime
  9. Contents of the pack and other information
    1. What Tarsime contains
    2. What Tarsime looks like and contents of the pack
    3. Marketing authorization holder and manufacturer
    4. Date of last revision of the package leaflet:
    5. Information intended for healthcare professionals only
    6. Intramuscular injections
    7. Intravenous injections
    8. Intravenous infusions
    9. For further information, please refer to the Summary of Product Characteristics.
    10. Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Package Leaflet: Information for the Patient

TARSIME, 750 mg, powder for solution for injection or infusion

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

TARSIME, 1500 mg, powder for solution for injection and infusion

Cefuroxime

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. See section 4.

Contents of the Package Leaflet

  • 1. What is Tarsime and what is it used for
  • 2. Important information before taking Tarsime
  • 3. How to take Tarsime
  • 4. Possible side effects
  • 5. How to store Tarsime
  • 6. Contents of the pack and other information

1. What is Tarsime and what is it used for

Tarsime is an antibiotic used in adults and children. The medicine works by killing bacteria sensitive to cefuroxime that cause infections. It belongs to a group of medicines called cephalosporins.

Tarsime is used to treat infections of:

  • the lungs or chest,
  • the urinary system,
  • the skin and soft tissues,
  • the abdomen.

Tarsime is also used:

  • to prevent infections during surgery.
Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. Important information before taking Tarsime

When not to take Tarsime:

  • if you are allergic (hypersensitive) to cefuroxime or any other cephalosporin antibiotic or any of the other ingredients of Tarsime;
  • if you have ever had a severe allergic reaction (hypersensitivity) to any other type of beta-lactam antibiotic (penicillins, monobactams or carbapenems);
  • if you have ever had a severe skin rash or blistering of the skin, or peeling and (or) mouth sores after taking cefuroxime or other cephalosporin antibiotics.
  • If you think any of these apply to you, tell your doctor before taking Tarsime. You should not take Tarsime.

before starting treatment with Tarsime. You must not take Tarsime.

Warnings and precautions

During treatment with Tarsime, pay attention to whether you experience any symptoms such as allergic reactions and stomach and gut disturbances (e.g. diarrhea). This will reduce the risk of complications (see "Symptoms to watch for" in section 4). If you have had allergic reactions to other antibiotics, such as penicillin, you may also be allergic to Tarsime. Severe, potentially life-threatening skin reactions have been reported with cefuroxime, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS). If you notice any of the symptoms associated with severe skin reactions described in section 4, seek medical advice immediately.

Blood and urine tests

Tarsime may affect the results of tests for sugar in the urine or blood, and a blood test called the Coombs test. If you are going to have these tests, you should:

  • tell the person taking the samplethat you are taking Tarsime.

Tarsime and other medicines

Tell your doctor about all the medicines you are taking now or have taken recently, and about any medicines you plan to take. This includes medicines that you can buy without a prescription. Some medicines may affect the action of Tarsime or increase the risk of side effects. These include:

  • aminoglycoside antibiotics
  • diuretics (water tablets), e.g. furosemide
  • probenecid
  • oral anticoagulants (blood thinners). If this applies to you, tell your doctor. You may need to have extra checks on your kidney function while taking Tarsime.

Oral contraceptives

Tarsime may reduce the effectiveness of oral contraceptives. If you are taking oral contraceptives while taking Tarsime, you should also use mechanical methods of contraception(e.g. condoms). Ask your doctor for advice.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor for advice before taking this medicine. Your doctor will assess whether the benefits of taking Tarsime during pregnancy and breastfeeding outweigh the risks to the baby.

Driving and using machines

You should not drive or operate machinery if you do not feel well.

Tarsime, 750 mg contains 38.6 mg of sodium (the main component of common salt) per vial.

This corresponds to 1.93% of the maximum recommended daily intake of sodium in the diet for adults. This should be taken into account in patients with reduced kidney function and in patients on a controlled sodium diet. Considering the dosing schedule presented in section 3, the maximum amount of sodium that can be administered to a patient in the maximum daily dose is 308.8 mg, which corresponds to 15.44% of the WHO-recommended maximum daily intake of 2 g of sodium for adults.

Tarsime, 1500 mg contains 77.3 mg of sodium (the main component of common salt) per vial.

This corresponds to 3.86% of the maximum recommended daily intake of sodium in the diet for adults. This should be taken into account in patients with reduced kidney function and in patients on a controlled sodium diet. Considering the dosing schedule presented in section 3, the maximum amount of sodium that can be administered to a patient in the maximum daily dose is 309.2 mg, which corresponds to 15.46% of the WHO-recommended maximum daily intake of 2 g of sodium for adults.

3. How to take Tarsime

Tarsime is usually given by a doctor or nurse.It can be given as an infusion (intravenous infusion)or as an injectiondirectly into a vein or muscle. The recommended dose will be decided by your doctor, taking into account the severity and type of infection, any other antibiotics you are taking, your body weight, age, and kidney function.

Newborns and infants (0-3 weeks old)

The dose is 30-100 mg of Tarsime per kilogram of body weight per day, divided into two or three doses.

Infants (over 3 weeks old) and children weighing less than 40 kg

The dose is 30-100 mg of Tarsime per kilogram of body weight per day, divided into three or four doses.

Adults and children weighing over 40 kg

750 mg to 1.5 g of Tarsime per day, divided into two, three, or four doses. Not more than 6 g per day.

Patients with kidney problems

If you have kidney problems, your doctor may change the dose of Tarsime.

  • If this applies to you, tell your doctor.

4. Possible side effects

Like all medicines, Tarsime can cause side effects, although not everybody gets them.

Symptoms to watch for

A small number of people taking Tarsime have reported an allergic reaction or potentially serious skin reaction. The symptoms may be:

  • allergic reaction with rash, itching, low blood pressure, swelling of the upper airways, sometimes of the face or mouth, which can make breathing difficult, including anaphylaxis, anaphylactic shock - rapidly progressing, life-threatening reactionswith dizziness, disorientation, and fainting due to insufficient blood flow to the organs;
  • angioedema (Quincke's edema)characterized by localized swelling of the skin and mucous membranes, which can be life-threatening if it occurs in the throat or larynx;
  • widespread skin changes (pink spots on the skin of the limbs and inside the mouth)with blisters and peeling skin;may be a sign of Stevens-Johnson syndrome or toxic epidermal necrolysis - Lyell's syndrome;
  • widespread rash, high fever, and swollen lymph nodes (DRESS syndrome or hypersensitivity syndrome);

bacterial or fungal infection;

  • severe hemolysis (breakdown of red blood cells),
  • thrombocytopenia (low platelet count),
  • high fever, vasculitis (inflammation of blood vessels),
  • interstitial nephritis (kidney inflammation), with fever, dull pain in the kidney area, and changes in laboratory tests: increased levels of urea and creatinine in the blood, decreased creatinine clearance.

If you experience any of these symptoms, contact your doctor or nurse immediately.

Other side effects that may occur during treatment

Frequent side effects (in 1 to 10 per 100 patients):

  • pain, swelling, and redness at the injection site
  • increased activity of liver enzymes
  • changes in white blood cell count (neutropenia or eosinophilia)
  • decreased hemoglobin levels in red blood cells.

Uncommon side effects (in 1 to 10 per 1,000 patients):

  • skin rash, urticaria, and itching
  • leukopenia (low white blood cell count)
  • gastrointestinal disorders
  • increased bilirubin levels (a substance produced by the liver)
  • positive Coombs test result.

Side effects with unknown frequency:

  • fungal or bacterial infection (Clostridioides difficile),
  • hemolytic anemia (rapid breakdown of red blood cells),
  • thrombocytopenia (low platelet count),
  • high fever, vasculitis (inflammation of blood vessels),
  • interstitial nephritis (kidney inflammation), with fever, dull pain in the kidney area, and changes in laboratory tests: increased levels of urea and creatinine in the blood, decreased creatinine clearance.

Reporting side effects

If you experience any side effects, including any not listed in this leaflet, please tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301; fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. You can also report side effects to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Tarsime

Keep the medicine out of the sight and reach of children. Store in a temperature below 25°C. Store in the original packaging to protect from light. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Tarsime contains

The active substance is cefuroxime (as cefuroxime sodium). Tarsime, 750 mg- one vial contains 750 mg of cefuroxime. Tarsime, 1500 mg- one vial contains 1500 mg of cefuroxime. Tarsime contains sodium (see section 2).

What Tarsime looks like and contents of the pack

White or almost white powder. Packaging: one vial in a cardboard box.

Marketing authorization holder and manufacturer

Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A., ul. A. Fleminga 2, 03-176 Warsaw, Phone: 22 811-18-14. For more detailed information on this medicine, please contact the marketing authorization holder.

Date of last revision of the package leaflet:

Information intended for healthcare professionals only

  • Preparation of solutions

Intramuscular injections

Add 4 mL of water for injections to the vial containing 750 mg of cefuroxime. Shake gently to obtain a uniform suspension.

Intravenous injections

Add approximately 9 mL or 15 mL of water for injections to the vial containing 750 mg or 1500 mg of cefuroxime, respectively. This gives a solution with a concentration of 83.3 mg/mL or 100 mg/mL, respectively. Shake gently to obtain a clear solution. Inject slowly over 3 to 5 minutes.

Intravenous infusions

Cefuroxime solutions prepared as for intravenous injections should be diluted to a volume of 50 to 100 mL with water for injections, 5% glucose solution, or 0.9% sodium chloride solution. Shake gently to obtain a clear solution. Administer through a large vein. The infusion should last 30 to 60 minutes. In accordance with good practice, solutions should be administered immediately after preparation. If the solution is not used immediately after preparation, the user is responsible for the storage time and conditions. The solution or suspension retains its stability at a temperature of 2°C to 8°C (in a refrigerator) for 24 hours, provided that the preparation of the solution is carried out under controlled aseptic conditions. A change in the color of the solutions to yellow or amber does not affect the activity or properties of the product.

  • Incompatibilities

Cefuroxime should not be mixed in a syringe with aminoglycoside antibiotics. Cefuroxime mixed with sodium bicarbonate solutions changes the color of the solution significantly, so it is not recommended to use it to dilute cefuroxime solutions. If necessary, a cefuroxime solution in water for injections can be introduced into the infusion line of a patient receiving a sodium bicarbonate infusion.

For further information, please refer to the Summary of Product Characteristics.

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Online doctors for Tarsime

Discuss questions about Tarsime, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(36)

Andrei Popov

General medicinePain medicine7 years of experience

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Book a video appointment
€86
Doctor
5.0(12)

Yevgen Yakovenko

Family medicine12 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Book a video appointment
€72
Doctor
5.0(3)

Lina Travkina

Family medicine13 years of experience

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Book a video appointment
€75
Doctor
5.0(2)

Dmytro Horobets

Family medicineEndocrinology7 years of experience

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Book a video appointment
€71
Doctor
5.0(19)

Nuno Tavares Lopes

Family medicineGeneral medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70

Get Tarsime Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Tarsime?

Tarsime does not require a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Tarsime?

The active ingredient in Tarsime is cefuroxime. This information helps identify medicines with the same composition but different brand names.

Who manufactures Tarsime?

Tarsime is manufactured by Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Tarsime online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Tarsime is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Tarsime in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Tarsime in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Tarsime?

Other medicines with the same active substance (cefuroxime) include Aprokam, Biofuroksim, Biofuroksim. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media